Table 1.
Key features of pathological vs. physiological hypertrophy and their mitochondrial alterations
Physiological hypertrophy | Pathological hypertrophy | |
---|---|---|
Stimuli | Volume overload (isotonic exercise) | Volume overload (valvular disease, aortovenous fistula) |
Pressure overload (isometric exercise) | Pressure overload (arterial hypertension, aortic constriction) | |
Pregnancy | ||
Foetal gene expression | Normal | Up-regulated |
Cardiac function | Normal/improved | Increasingly impaired during the time course |
Decompensation | Not occuring | Occuring |
Cardiac structure | Increased myocyte volume | Increased myocyte volume |
Formation of new sarcomers | Formation of new sarcomers | |
Interstitial fibrosis | ||
Increased rates of apoptosis | ||
Fatty acid oxidation | Unchanged or increased | Decreased |
Glucose oxidation | Unchanged or increased | Unchanged |
Maybe reduced during heart failure | ||
Mitochondrial biogenesis | In accordance to cellular hypertrophy | Unchanged during compensated hypertrophy |
Maybe diminished during heart failure | ||
ATP production | Sufficient | Impaired |